These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19190977)

  • 1. Rapid decrease of anti-beta-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoshida M; Ishibashi K; Hida S; Yoshikawa N; Nakabayashi I; Akashi M; Watanabe T; Tomiyasu T; Ohno N
    Clin Rheumatol; 2009 May; 28(5):565-71. PubMed ID: 19190977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
    Palsson R; Choi HK; Niles JL
    J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
    Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
    Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.
    Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD
    Arthritis Rheum; 2010 May; 62(5):1539-48. PubMed ID: 20155828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the titer and reactivity of antibody/ies against fungal cell wall β-glucans in human sera.
    Ishibashi K; Morita M; Motoi M; Liu Y; Miura NN; Adachi Y; Ohno N
    Int J Med Mushrooms; 2013; 15(2):115-26. PubMed ID: 23557364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
    Almroth G; Berlin G; Andersson B; Hahn-Zoric M
    Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infection in ANCA-associated vasculitis: Between the Devil and Deep blue sea. Case series and review of the literature.
    Baliga S; Yadav S; Sagdeo P; Balakrishnan C
    Clin Rheumatol; 2024 Feb; 43(2):785-797. PubMed ID: 37798405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rise in antineutrophil cytoplasmic antibody in a patient with systemic vasculitis in remission.
    Kaname S; Uchida S; Minoda S; Arimura Y; Nagasawa T; Asano S; Ogata E
    Nephron; 1994; 68(3):380-4. PubMed ID: 7838265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
    Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.
    Haubitz M; Schulzeck P; Schellong S; Schulze M; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Sep; 40(9):1680-4. PubMed ID: 9324023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis.
    Watanabe S; Gono T; Nishina K; Sugitani N; Watanabe E; Yabe H; Terai C
    BMC Immunol; 2017 Dec; 18(1):53. PubMed ID: 29262790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.